PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Pregabalin - Pain
PAD Profile : Pregabalin - Pain Important
Keywords :
analgesic, analgesia
Brand Names Include :
Lyrica
Important Information :
Not for chronic or acute, non-malignant pain. See separate formulary entry for use in neuropathic pain
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Oxycodone
- Co-codamol (Codeine phosphate/paracetamol)
- Tramadol hydrochloride
- Oxycodone hydrochloride/naloxone hydrochloride
- Fentanyl
- Tramadol hydrochloride
- Tramadol hydrochloride
- Paracetamol
- Codeine phosphate
- Dihydrocodeine tartrate
- Buprenorphine
- Morphine sulfate
- Gabapentin
- Dronabinol/cannabidiol
- Co-dydramol (Dihydrocodeine/paracetamol)
- Ibuprofen
- Meptazinol hydrochloride
- Pethidine hydrochloride
- Diamorphine hydrochloride
- Alfentanil hydrochloride
- Co-dydramol (Dihydrocodeine/paracetamol)
- Co-dydramol (Dihydrocodeine/paracetamol)
- Nefopam hydrochloride
- Papaveretum
- Aspirin
Other Indications
Additional Documents
Type
Document
Review Date
Safety Information
01 August 2023
Committee Recommendations
Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Pregabalin is not recommended as a treatment option for persistent non-malignant pain (including low back pain) and will be considered BLACK on the traffic light system. Please see the persistent non- malignant guidelines attached below for information on prescribing for this indication.
Associated BNF Codes
04. Central Nervous System
04.07.03. Neuropathic pain